만성 구강안면통증의 조절을 위한 약물치료적 접근
Pharmacological approaches for the management of chronic orofacial pain
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chronic orofacial pain is an umbrella term as a kind of painful regional syndromes to describe unremitting and prolonged pains in orofacial area. It is frequently characterized with the intractable pain without the proportionally corresponding tissue pathology over 3 months. Accordingly, it is difficult or almost impossible to establish the causally oriented treatment strategies in those cases, while multidisciplinary approaches were usually considered for preventing prolonged pain conditions from limiting daily life. Among a variety of approaches, pharmacological approach was clinically based on proper applications of several groups of drugs useful to relieve or alleviate pain. These drugs usually encompass several analgesics, muscle relaxants, anti-depressants, anticonvulsants and so on. Therefore, it is essential for dental clinician to be aware of the many peculiarities of these medications applied for management of chronic orofacial pain disorders. This review focused on the clinical considerations for the careful drug selection and application including dosages and adverse drug reactions.
Abstract
Chronic orofacial pain is an umbrella term as a kind of painful regional syndromes to describe unremitting and prolonged pains in orofacial area. It is frequently characterized with the intractable pain without the proportionally corresponding tissue pathology over 3 months. Accordingly, it is difficult or almost impossible to establish the causally oriented treatment strategies in those cases, while multidisciplinary approaches were usually considered for preventing prolonged pain conditions from limiting daily life. Among a variety of approaches, pharmacological approach was clinically based on proper applications of several groups of drugs useful to relieve or alleviate pain. These drugs usually encompass several analgesics, muscle relaxants, anti-depressants, anticonvulsants and so on. Therefore, it is essential for dental clinician to be aware of the many peculiarities of these medications applied for management of chronic orofacial pain disorders. This review focused on the clinical considerations for the careful drug selection and application including dosages and adverse drug reactions.
참고문헌 (13)
- 민양기, "신경병성 통증의 진단과 치료", 대한의사협회지, 51(12), pp.1139~1148 (2008), 대한의사협회
- Okeson JP, "Bell's orofacial pains: the clinical management of orofacial pain" (2005), Quintessence Publishing Company
- 조상훈, "치과 개원의를 위한 약 처방 이야기" (2017), (주)예낭아이엔씨
- 대한안면통증 구강내과학회, "구강내과학 제4편구강안면통증과 측두하악장애" (2012), (주)예낭아이앤씨
- 임재영, "노인의 만성통증의 최신 약물 치료 지침", 2010대한임상노인의학회 춘계학술대회 자료집, pp.85~92 (2010)
- Laskin DM, "Temporomandibular disorders: an evidence-based approach to diagnosis and treatment" (2006), Quintessence Publishing Company
- 이경규, "만성 통증 환자에서의 정신약물학적 치료", 대한정신약물학회지, 19(2), pp.77~84 (2008), 대한정신약물학회
- 문동언, "만성통증 환자에서 항우울제의 사용", The Korean Journal of Pain, 17(2), pp.9~9 (2004), 대한통증학회
- Al-Quliti KW, "Update on neuropathic pain treatment for trigeminal neuralgia. the pharmacological and surgical options", Neuro sciences(Riyadh), 20, pp.107~114 (2015)
- Schmidt D, "What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs", Epilepsy Behav, 5, pp.627~635 (2004)
- Canavero S, "Drug therapy of trigeminal neuralgia", Expert Rev Neurother, 6, pp.429~440 (2006)
- Grevert P, "Partial antagonism of placebo analgesia by naloxone", Pain, 16, pp.129~143 (1983)
- Stockstill JW, "The placebo effect. the placebo effect in the management of chronic myofascial pain: A review", J Am Coll Dent, 56, pp.14~18 (1989)